Boston-based Verve is a rare example of a gene-editing company targeting a disease that affects a large population, offering ...

BioSpace did a deep dive into executive pay, examining the highest compensation packages, pay ratios and golden ...

Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on foreign trade deals and warned of the harmful effects retaliatory tariffs could have on American exporters like Eli Lilly.

Chief Executive magazine announced April 7 that Dave Ricks, chair and CEO of Eli Lilly and Company, has been named 2025 Chief Executive of the Year. Ricks is the newest member of the Purdue University ...

David Ricks is the CEO of Eli Lilly, the most valuable drugmaker in the world by market capitalization. Lilly is on the path to become the first trillion-dollar pharma company, fueled by the ...

However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every ...

David Ricks thinks Trump's tariffs will eventually target drugmakers. The results could be harmful to them in more ways than one. Despite this issue, Eli Lilly remains a top stock to buy.

However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Let's see what he had to say about the potential impact of tariffs, and what ...

Eli Lilly CEO Dave Ricks made $114 million in 2024, according to a new proxy statement to investors, putting him in the rare company of health care executives who have pulled in at least nine ...

David Ricks, Chair and C.E.O. of Eli Lilly and Company, speaks during the New York Times annual DealBook summit at Jazz at Lincoln Center on December 04, 2024 in New York City. - Image: Michael M ...